NTVH - 2024, nummer Gentherapie special, oktober 2024
Dr. Natasja Otto
Ondanks dat de ziekte van von Willebrand (VWZ) een monogenetische aandoening is, veroorzaakt door mutaties in een enkel gen, zijn er nog geen gen- of gengerichte therapieën beschikbaar. We spreken over de nieuwste ontwikkelingen, knelpunten en toekomstverwachtingen van zulke therapieën met prof. dr. Frank Leebeek, prof. dr. Jeroen Eikenboom en prof. dr. Jan Voorberg.
Lees verderTo provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site and show (non-) personalized ads. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Click below to consent to the above or make granular choices. Your choices will be applied to this site only. You can change your settings at any time, including withdrawing your consent, by using the toggles on the Cookie Policy, or by clicking on the manage consent button at the bottom of the screen.
